Mar 3 2027in 166 days
—
$3.03B
2 of last 2
Each report against the estimate that stood when it landed.
| Reported | EPS est | EPS actual | Surprise | Revenue est | Revenue actual | Surprise |
|---|---|---|---|---|---|---|
| Aug 19 2026 | $23.13 | $23.13 | +0.0% | $2.82B | $2.87B | +1.8% |
| Feb 26 2026 | — | $30.64 | — | $3.05B | $3.13B | +2.7% |
| Aug 20 2025 | — | $22.88 | — | $2.79B | $2.86B | +2.4% |
| Feb 26 2025 | — | $23.86 | — | $2.57B | $2.57B | -0.0% |
| Aug 14 2024 | — | $21.77 | — | $2.26B | $2.25B | -0.4% |
| Apr 11 2024 | — | $19.33 | — | $2.54B | $2.50B | -1.6% |
| Jun 30 2023 | — | $20.38 | — | $2.34B | $2.35B | +0.2% |
| Dec 31 2022 | — | $21.10 | — | $2.25B | $2.39B | +6.3% |
| Jun 30 2022 | — | $15.25 | — | $2.02B | $2.10B | +4.4% |
| Dec 31 2021 | — | $24.13 | — | $2.22B | $2.22B | -0.2% |
| Jun 30 2021 | — | $19.97 | — | $1.96B | $2.04B | +4.0% |
| Dec 31 2020 | $18.44 | $22.64 | +22.8% | $2.19B | $2.19B | -0.0% |
No earnings transcripts available for EMLZF
Transcripts may not be available for all companies
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $4.64B | $4.77B | $4.90B |
| Low | $4.62B | $4.74B | $4.88B |
| High | $4.66B | $4.81B | $4.93B |
| EBITDA Avg | $473M | $507M | $538M |
| Low | $471M | $504M | $536M |
| High | $475M | $509M | $541M |
| EBIT Avg | $313M | $343M | $372M |
| Low | $311M | $341M | $369M |
| High | $315M | $346M | $374M |
| Net Income Avg | $226M | $250M | $272M |
| Low | $224M | $248M | $270M |
| High | $228M | $252M | $274M |
| EPS Avg | $42.25 | $46.68 | $50.80 |
| Low | $41.96 | $46.36 | $50.45 |
| High | $42.58 | $47.04 | $51.19 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 2 / 1 |